New hope for kids with rare cancer: modified chemo shows promise
NCT ID NCT04881838
First seen Mar 24, 2026 · Last updated Apr 30, 2026 · Updated 7 times
Summary
This study tests a modified chemotherapy regimen (ALCL99) in 172 Chinese children and teens with newly diagnosed high-risk anaplastic large cell lymphoma. The goal is to see if the modified treatment improves 3-year survival without the cancer coming back, compared to past results. Researchers will also track side effects and how well patients follow the treatment plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Children's Medical Center
Shanghai, China
Conditions
Explore the condition pages connected to this study.